NovaBay Pharmaceuticals Stock (AMEX: NBY) stock price, news, charts, stock research, profile.
Open | $0.110 |
Close | $0.105 |
Volume / Avg. | 2.093M / 3.558M |
Day Range | 0.103 - 0.110 |
52 Wk Range | 0.101 - 1.950 |
Market Cap | $3.348M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 30 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NovaBay Pharmaceuticals (AMEX: NBY) through any online brokerage.
There are no as such competitors for NovaBay Pharmaceuticals.
The latest price target for NovaBay Pharmaceuticals (AMEX: NBY) was reported by Ladenburg Thalmann on Friday, August 11, 2023. The analyst firm set a price target for 3.80 expecting NBY to fall to within 12 months (a possible NaN% downside). 1 analyst firms have reported ratings in the last year.
The stock price for NovaBay Pharmaceuticals (AMEX: NBY) is $ last updated .
There are no upcoming dividends for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.